Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;19(6):521-529.
doi: 10.3988/jcn.2022.0358. Epub 2023 Apr 18.

Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies

Affiliations

Neuropsychological Comparison of Patients With Alzheimer's Disease and Dementia With Lewy Bodies

Sungwoo Kang et al. J Clin Neurol. 2023 Nov.

Abstract

Background and purpose: This study aimed to determine the neuropsychological differences between patients with early-stage Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) with a Clinical Dementia Rating (CDR) score of ≤1.

Methods: We examined 168 patients with AD (126 with CDR score=0.5, 42 with CDR score=1) and 169 patients with DLB (104 with CDR score=0.5, 65 with CDR score=1) whose diagnoses were supported by 18F-flobetaben positron-emission tomography (PET) and 18F-N-(3-fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane PET. Neuropsychological test scores were compared after controlling for age, sex, and education duration. Using a cutoff motor score on the Unified Parkinson's Disease Rating Scale of 20, patients with AD were further divided into AD with parkinsonism (ADP+, n=86) and AD without parkinsonism (ADP-, n=82).

Results: At CDR scores of both 0.5 and 1, the DLB group had lower scores on the attention (digit-span forward at CDR score=0.5 and backward at CDR score=1), visuospatial, and executive (color reading Stroop test at CDR score=0.5 and phonemic fluency test, Stroop tests, and digit symbol coding at CDR score=1) tests than the AD group, but higher scores on the memory tests. The ADP- and ADP+ subgroups had comparable scores on most neuropsychological tests, but the ADP+ subgroup had lower scores on the color reading Stroop test.

Conclusions: Patients with DLB had worse attention, visuospatial, and executive functions but better memory function than patients with AD. Parkinsonism was not uncommon in the patients with AD and could be related to attention and executive dysfunction.

Keywords: Alzheimer disease; dementia with Lewy bodies; neuropsychological assessment.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. Comparisons of the proportion of cognitive impairment between the AD and DLB groups. Stacked bar graph illustrating the proportions of subjects with cognitive impairment according to each neuropsychological test. The proportion of subjects with z scores less than mean-1.0×SD for age- and education-matched norms are shown in bright green, while that of subjects with z scores less than mean-1.5×SD are in dark green. Stars denote significant differences (p<0.05) in the comparisons between the AD and DLB groups after corrections for multiple comparisons across 16 neuropsychological tests using the false discovery rate method. Bright stars represent significant difference in the proportion of subjects with z scores less than mean-1.0×SD, and dark stars represent z scores less than mean-1.5×SD. AD, Alzheimer’s disease; COWAT, Controlled Oral Word Association Test; DLB, dementia with Lewy bodies; DSC, digit symbol coding; K-BNT, Korean version of the Boston Naming Test; K-CWST, Korean version of the color-word Stroop test; K-TMT-E, Korean version of the Trail-Making Test for the Elderly; RCFT, Rey-Osterrieth Complex Figure Test; SD, standard deviation; SVLT, Seoul Verbal Learning Test.

Comment in

References

    1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–269. - PMC - PubMed
    1. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88–100. - PMC - PubMed
    1. Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5–36. - PubMed
    1. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124. - PubMed
    1. Irwin DJ, Hurtig HI. The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders. J Alzheimers Dis Parkinsonism. 2018;8:444. - PMC - PubMed